Neuland Laboratories Q4 Results

  • BSE: 524558
  • NSE: NEULANDLAB
  • ISIN: INE794A01010
  • Sector: Major Drugs
BSE
14,872.95-31.30 (-0.21%)
Volume644.00
Updated: Mon 25 Nov, 2024 | 15:49:14
NSE
14,853.95-51.00 (-0.34%)
Volume32.98 K
Updated: Mon 25 Nov, 2024 | 15:43:10
Today: 14,703.00
15,466.90
52-Wk: 4,928.00
16,544.75

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Neuland Laboratories Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 385.01269.25-%407.07-%
    Selling/ General/ Admin Expenses Total 62.4951.62-%49.53-%
    Depreciation/ Amortization 16.4613.34-%13.47-%
    Other Operating Expenses Total 35.5824.11-%29.03-%
    Total Operating Expense 294.56228.50-%300.68-%
    Operating Income 90.4540.75-%106.39-%
    Net Income Before Taxes 92.2038.94-%110.16-%
    Net Income 67.5630.55-%84.54-%
    Diluted Normalized EPS 52.6623.81-%65.91-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts